U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07294846) titled 'Drug Interaction Study on Linaprazan Glurate Capsules' on Sept. 04.
Brief Summary: This study is a drug-drug interaction (DDI) investigation involving Linaprazan Glurate capsules and a combination of clarithromycin tablets, amoxicillin capsules, and bismuth potassium citrate capsules. The study plan is divided into two parts: one involving Hp-negative healthy subjects and the other involving Hp-positive subjects.
Study Start Date: Sept. 08
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Patients
Intervention:
DRUG: Linaprazan Glurate Capsules
Linaprazan Glurate capsules
DRUG: Bismuth Potassium Citrate Capsules
Bism...